Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Urologix CEO Stryker Warren To Retire

Urologix, Inc. (ULGX: Quote) said Tuesday that Stryker Warren jr. has decided to retire as CEO and a member of the company's Board of Directors, effective November 30.

The company said its Chief Operating Officer Greg Fluet will become interim CEO following Warren's retirement.

Fluet joined the company as its Executive Vice President and Chief Operating Officer in July 2008. Prior to joining Urologix, he was an Associate at Sapient Capital Management, LLC, a venture capital firm focused on medical devices.

Warren came out of retirement to join Urologix as CEO in June 2008. He had previously been the President and CEO of Urology Healthcare Group whose wholly owned subsidiary, Urotech, remains Urologix' largest customer.

Click here to receive FREE breaking news email alerts for UROLOGIX INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.